宫颈癌近距离放射治疗疼痛管理的研究进展

doi:10.13481/j.1671-587x.20190140

[1] KARLSSON J,DREIFALDT A C,MORDHORST L B, et al. Differences in outcome for cervical cancer patients treated with or without brachytherapy[J]. Brachytherapy, 2017, 16(1):133-140.
[2] WANG W,HOU X,YAN J, et al. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women[J]. BMC Cancer, 2017, 17(1):510.
[3] KWEKKEBOOM K L,DENDAAS N R,STRAUB M, et al. Patterns of pain and distress during high-dose-rate intracavity brachytherapy for cervical cancer[J]. J Support Oncol, 2009, 7(3):108-114.
[4] WARNOCK C. Patients' experiences of intracavity brachytherapy treatment for gynaecological cancer[J]. Eur J Oncol Nurs, 2005, 9(1):44-55.
[5] ROLLISON B,STRANG P. Pain, nausea and anxiety during intra-uterine brachytherapy of cervical carcinomas[J]. Support Care Cancer, 1995, 3(3):205-207.
[6] WIEBE E,SURRY K,DERRAH L, et al. Pain and symptom assessment during multiple fractions of gynecologic high-dose-rate brachytherapy[J]. Brachytherapy, 2011,10(5):352-356.
[7] BHANABHAI H,SAMANT R,E C, et al. Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy[J]. Curr Oncol, 2013, 20(4):e307-310.
[8] CORN B W,HANLON A L,PAJAK T F, et al. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix[J]. Gynecol Oncol, 1994, 53(3):294-300.
[9] WATANABE NEMOTO M,NOZAKI-TAGUCHI N,TOGASAKI G, et al. New approach to relieving pain and distress during high-dose-rate intracavitary irradiation for cervical cancer[J]. Brachytherapy, 2015, 14(5):642-647.
[10] BANSAL R,KHAN JOAD A S,SAXENA M, et al. Oral midazolam is a safe and effective premedication in adult outpatients undergoing brachytherapy for cancer cervix under general anaesthesia:A prospective randomised, double blind placebo-controlled study[J]. Indian J Anaesth, 2015,59(7):437-439.
[11] KAMER S,OZSARAN Z,CELIK O, et al. Evaluation of anxiety levels during intracavitary brachytherapy applications in women with gynecological malignancies[J]. Eur J Gynaecol Oncol, 2007, 28(2):121-124.
[12] HILLER J G,ISMAIL H M,HOFMAN M S, et al. Neuraxial anesthesia reduces lymphatic flow:proof-of-concept in first in-human study[J]. Anesth Analg, 2016, 123(5):1325-1327.
[13] SMITH M D, TODD J G,SYMONDS R P. Analgesia for pelvic brachytherapy[J]. Br J Anaesth, 2002, 88(2):270-276.
[14] VISWANATHAN A N,CREUTZBERG C L,CRAIGHEAD P, et al. International brachytherapy practice patterns:a survey of the Gynecologic Cancer Intergroup (GCIG)[J]. Int J Radiat Oncol Biol Phys, 2012, 82(1):250-255.
[15] JONES B,TAN L T,BLAKE P R, et al. Results of a questionnaire regarding the practice of radiotherapy for carcinoma of the cervix in the UK[J]. Br J Radiol, 1994, 67(804):1226-1230.
[16] PETRIC P,HUDEJ R,HANUNA O, et al. MRI-assisted cervix cancer brachytherapy pre-planning, based on application in paracervical anaesthesia:final report[J]. Radiol Oncol, 2014, 48(3):293-300.
[17] PROUD C. The use of oral transmucosal fentanyl citrate during high-dose-rate gynecologic brachytherapy[J]. Clin J Oncol Nurs, 2007, 11(4):561-567.
[18] XU-WELLIVER M,LIN L L. Evaluation of a balloon-based vaginal packing system and patient-controlled analgesia for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy[J]. Pract Radiat Oncol, 2013, 3(4):263-268.
[19] LEONG Y H,TAN K H S,AI CHOO B, et al. Novel anesthetic technique for combined intracavitary and interstitial brachytherapy for cervix cancer in an outpatient setting[J]. J Contemp Brachytherapy, 2017, 9(3):236-241.
[20] TAN P W, KOH V Y, TANG J L. Outpatient combined intracavitary and interstitial cervical brachytherapy:barriers and solutions to implementation of a successful programme-a single institutional experience[J]. J Contemp Brachytherapy, 2015, 7(3):259-263.
[21] TANGSIRIWATTHANA T,SANGKOMKAMHANG U S,LUMBIGANON P, et al. Paracervical local anaesthesia for cervical dilatation and uterine intervention[J]. Cochrane Database Syst Rev, 2009(1):CD005056.
[22] ANBUMANI S,ANCHINEYAN P,NARAYANASAMY A, et al. Treatment planning methods in high dose rate interstitial brachytherapy of carcinoma cervix:a dosimetric and radiobiological analysis[J]. ISRN Oncol, 2014, 2014:125020.
[23] TSUJINO K. The impact of general anesthesia usage during hdr intracavitary brachytherapy for cervical cancer on the quality of applicationsujino 2011[J]. Hyogo Cancer Center, 2011(2):S453-S454.
[24] LIM K H,LU J J,WYNNE C J, et al. A study of complications arising from different methods of anesthesia used in high-dose-rate brachytherapy for cervical cancer[J]. Am J Clin Oncol, 2004, 27(5):449-451.
[25] SHARMA D N,CHAUDHARI P,SHARMA S, et al. Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma[J]. J Appl Clin Med Phys, 2014, 15(2):4670.
[26] JANAKI M G,NIRMALA S,KADAM A R, et al. Epidural analgesia during brachytherapy for cervical cancer patients[J]. J Cancer Res Ther, 2008, 4(2):60-63.
[27] VISWANATHAN A N,THOMADSEN B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I:general principles[J]. Brachytherapy, 2012, 11(1):33-46.
[28] ROESSLER B,SIX L M,GUSTORFF B. Anaesthesia for brachytherapy[J]. Curr Opin Anaesthesiol, 2008, 21(4):514-518.
[29] BENRATH J,KOZEK-LANGENECKER S,HVPFL M, et al. Anaesthesia for brachytherapy-51/2 yr of experience in 1622 procedures[J]. Br J Anaesth, 2006, 96(2):195-200.
[30] WOJCIESZEK E,REMBIELAK A,BIALAS B, et al. Anaesthesia for radiation therapy-Gliwice experience[J]. Neoplasma, 2010, 57(2):155-160.
[31] WEITMANN H D,GUSTORFF B,VAUPEL P, et al. Oxygenation status of cervical carcinomas before and during spinal anesthesia for application of brachytherapy[J]. Strahlenther Onkol, 2003, 179(9):633-640.
[32] KIRCHHEINER K,CZAJKA-PEPL A,PONOCNY-SELIGER E, et al. Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal/epidural anesthesia:incidence and risk factors[J]. Int J Radiat Oncol Biol Phys, 2014, 89(2):260-267.
[33] JAIN R,MISHRA S, BHATNAGARS. Comparison of different anaesthetic techniques for high-dose-rate intracavitory radiotherapy for carcinoma cervix[J]. Int J Anesthesiol, 2008,17(1):8.
[34] MICHALEK-SAUBERER A, KOZEK-LANGENECKER S A,HEINZL H, et al. Median effective local anesthetic doses of plain bupivacaine and ropivacaine for spinal anesthesia administered via a spinal catheter for brachytherapy of the lower abdomen[J]. Reg Anesth Pain Med, 2008, 33(1):4-9.
[35] AMSBAUGH A K,AMSBAUGH M J,EL-GHAMRYM N, et al. Optimal epidural analgesia for patients diagnosed as having gynecologic cancer undergoing interstitial brachytherapy[J]. J Clin Anesth, 2016, 35:509-515.
[36] NIELSEN A A,LIYANAGE T A,LEISEROWITZ G S, et al. Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy[J]. J Contemp Brachytherapy, 2017, 9(3):216-223.
[37] DAWKINS C J. An analysis of the complications of extradural and caudal block[J]. Anaesthesia, 1969, 24(4):554-563.
[38] NAG S, ERICKSON B,THOMADSEN B, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix[J]. Int J Radiat Oncol Biol Phys, 2000, 48(1):201-211.
[39] CHEN H C, LEUNG S W,WANG C J, et al. Local vaginal anesthesia during high-dose-rate intracavitary brachytherapy for cervical cancer[J]. Int J Radiat Oncol Biol Phys, 1998, 42(3):541-544.
[40] COUTAUX A,SALOMON L,ROSENHEIM M, et al. Care related pain in hospitalized patients:a cross-sectional study[J]. Eur J Pain, 2008, 12(1):3-8.
[41] MENDEZ L C,CHOI S,D'ALIMONTE L, et al. Opioid consumption and pain in gynecological cancer patients treated with interstitial brachytherapy[J]. Brachytherapy, 2017, 16(4):870-876.

Research progress in pain management of cervical cancer during brachytherapy

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LI Hongxia, GONG Haiye, ZENG Xiao, ZHANG Susu, LIU Bofeng. Expressions of TGF-β1 and PLGF in tissue of patients with different types of gestational trophoblastic diseases and their significances [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1041-1046.
[2]	AN Le, YANG Jianzheng, HU Chunmei, YU Qiong, XIAO Han, HAO Shuhong, TANG Yan. Anti-apoptosis effect of polycystin-1 gene on human cervical cancer HeLa cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 776-779.
[3]	XU LI, ZHANG Wei. Induction of oxaziridine on apoptosis of human cervical cancer HeLa cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1161-1164.
[4]	WEN Simin, YU Duo, LYU Xin, WANG Tiejun. Influence of docetaxel combined with cisplatinand single-agent cisplatin concurrent chemoradiotherapy in prognosis of patients with advanced cervical cancer and evaluation on security [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1002-1008.
[5]	DENG Ziliang, WANG Sen, LI Peng, XIE Kuilong, LI Shuxian, ZHOU Shixiong, HE Xiaozhou, CHEN Dong, GUO Hongsheng. Enhancement of IL-37 in chemosensitivity of cervical cancer HeLa cells to cisplatin [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 862-866.
[6]	JIANG Xueyuan, PIAO Xianji, LIU Chang, LUO Yinghua, SUN Hunan, HAN Yinghao, SHEN Guinan, ZANG Yanqing, JIN Chenghao. Apoptotic effect of 4,5,6,7-tetrabromobenzotriazole on human cervical cancer HeLa cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2017, 43(03): 561-565.
[7]	QIANG Xin, HUO Wenyan, YANG Can, FAN Yanan, SHI Caiyun, BAI Haihua. Expressions of p16INK4a protein in cervical lesion tissues of Mongolian patients and their significances [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 353-355.
[8]	. Progress research on role of ALDH1 in occurrence and development of cervical cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 196-199.
[9]	LIU Qianqian, SUN Lei, BIAN Li, HAN Jinhua, JIA Xiuxiu, YAO Xiaoqing, CHEN Yubing, SONG Xinling. Relationship between cognitive differences in medical behaviors and degrees of anxiety of cervical cancer patients undergoing radiotherapy [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 115-119.
[10]	XU Lu, ZENG Linchuan, YU Yang, DOU Minghan, LU Shibing, LI Songyan, XU Ye. Role of Ca²⁺ in cisplatin-induced autophagy of cervical cancer HeLa cells [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1045-1048.
[11]	WEN Aiping, WANG Haijiao, JIN Jingji, CAI Yong, ZHU Jihong, CHEN Lunhua. Expressions of hMOFprotein and mRNA in endometrial cancer tissue and their clinical significances [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1138-1142.
[12]	CHEN Moran, ZHAO Xingyu, LUO Jun, ZHU Wenhe, LI Yan, ZHANG Wei. Pomotion effect of juglone combined with cisplatin on apoptosis of human cervical cancer HeLa cells and its mechanism [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 901-904.
[13]	WANG Zhiliang, YU Tenghua, QIN Qin, WU Yutong, ZHANG Wenqian, HUA Yuanyuan, XIONG Zhengai, ZHOU Wei. Influence of irreversible electroporation mediated HPV16 E6 shRNA interference plasmid in proliferation of cervical cancer SiHa cells [J]. Journal of Jilin University Medicine Edition, 2015, 41(06): 1107-1112.
[14]	TIAN Jing, ZOU Rongjun, LIANG Zufeng, SHI Wanting, QI Ling, LI Yan. Inhibitory effects of niflumic acid on apoptosis induced by cobalt chloride in hippocampus neurons [J]. Journal of Jilin University Medicine Edition, 2015, 41(05): 914-918.
[15]	LIU Hong-li,LYU Chang-shuai,DING Bai-juan,WANG Jie,LI Shan,ZHANG You-zhong. Photodynamic effect of new photodynamic therapy combined with nucleolin silenceon cervical cancer cell line SiHa [J]. Journal of Jilin University Medicine Edition, 2014, 40(04): 748-752.